RxDoctor Payments Data

Bruce Lawrence

Podiatrist · Oceanside, CANPI 1417024852

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $809,438 of the $809,563 with a category attached, or 100.0%. 4 manufacturers reported payments, led by Smith+Nephew at 58.3% of the total. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$809,563in general payments, 2019–2025

Across 59 payments — averaging $13,721 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$472K
  • Integra Lifesciences Corporation$308K
  • Stryker$29K
  • Boston Scientific$125

What the payments were for

  • Royalty or licence$809,438100%
  • Food & beverage$1250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew19$471,731
Integra Lifesciences Corporation9$308,217
Stryker(2 entities)30$29,490
Boston Scientific1$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$809,563 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California →

Other podiatrist in Oceanside

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →